Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-04-12

Clinical Trial Update: Visceral Artery Aneurysm Embolization by the Penumbra Ruby™ Coil System [Phase 4]

View source ↗

Summary

Phase 4 trial of the Penumbra Ruby Coil System for visceral artery aneurysm embolization was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ruby Coil System

Snippet

Sponsor: Penumbra Inc. | Conditions: Visceral Artery Aneurysms, Arteriovenous Malformations | Phase 4 | Status: WITHDRAWN